Most Popular Stories
- Illegal-immigrant issues may threaten passage of House reform bill
- Physician-owned hospitals unfairly targeted by health reform, group argues
- UnitedHealth Group's Stephen Hemsley - CEO Compensation
- International study finds U.S. behind in access, quality
- Nurses in ICUs get worse sleep, may make more errors
- Health IT stimulus includes Medicare EMR incentives
Featured Jobs
-
Emergency Department Clinical Mgr Job in MD
StaffPointe, LLC - Baltimore, MD -
Orthopedic Surgeon Job for New Hampshire
StaffPointe, LLC - south, NH -
Family Practice/HIV Job in Florida
StaffPointe, LLC - south, FL -
PHYSICIANS- DO YOU WANT A BETTER LIFE?
HCL International - New York -
Neurology Job in New York City
StaffPointe, LLC - Manhattan, NY
Events
- Mobile Healthcare Industry Summit
1-2 Dec 09 — London - Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT - IHI's 21st Annual National Forum on Quality Improvement in Health Care
December 6-9 — Orlando, FL
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Hospital Fires | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
Avandia slammed by more studies
Two more studies have come out which raise further questions about the safety of diabetes drug Avandia. The first of the two studies, which were published in The Journal of the American Medical Association, found that Avandia doubled the risk of heart failure and raised the risk of heart attack by 42 percent. Like the high-profile research published in May, the first in recent times to slam Avandia, this research involved a combined analysis of other Avandia studies. The second JAMA study found that Actos, a similar drug, lowered the risk of heart attacks, strokes and death, though it also raised risks of heart failure. Avandia maker GlaxoSmithKline continues to contest the results of such research; in this case, it argued that the studies were flawed.
To learn more about the studies:
- read this piece from The New York Times
Related Articles:
FDA panel votes to keep Avandia on the market. Report
Avandia risks exposed under deal to post data. Report
Avandia controversy sparks FDA criticism. Report
Glaxo: Avandia critic should pay for stock drop. Report
Diabetes expert issued harsh Avandia critique in 2000. Report
Related Stories
- Avandia gets black-box warning
- FDA, drug makers to study drug side-effects
- Dialysis firms defend anemia drug use along ethnic lines
- FDA plans to study TV drug ads
- Studies raise questions about how much drug safety info should be released
- More objections to Avandia suppressed by Glaxo
- FDA to notify doctors of drug, device issues via Internet
- CMS awards $7M to top performers in P4P program
- Did Glaxo conceal Paxil users' risk of suicide?
- Study: Admission day dictates heart failure, length of stay
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





